Search Results - "Mancusi, Daniela"
-
1
Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load
Published in PloS one (16-02-2018)“…A regimen with rilpivirine (RPV), abacavir (ABC) and lamivudine (3TC) is simple and may allow the sparing of tenofovir and protease inhibitors. However, data…”
Get full text
Journal Article -
2
Cardiovascular disease in women with HIV-1 infection
Published in International journal of cardiology (15-08-2017)“…Abstract Cardiovascular disease is a leading cause of death in women, nevertheless it is often underestimated in female patients without overt risk factors…”
Get full text
Journal Article -
3
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor–Based Regimen: The “STORE” Study
Published in Journal of acquired immune deficiency syndromes (1999) (01-07-2020)“…OBJECTIVE:This study investigates the effectiveness and tolerability of switching to a darunavir/cobicistat (DRV/c)-based antiretroviral regimen from a…”
Get full text
Journal Article -
4
Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum]
Published in Drug design, development and therapy (30-11-2022)“…Ranzenigo M, Gianotti N, Galli L, et al. Drug Des Devel Ther. 2022;16:1975-1982. Page 1975, Abstract, Results, line five, the text "the ongoing regimen was…”
Get full text
Journal Article -
5
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice
Published in Drug design, development and therapy (01-01-2022)“…Background: The primary objective of this study was to estimate the proportion of people living with HIV (PLWH) who switched from a non-protease inhibitor…”
Get full text
Journal Article -
6
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression
Published in The patient : patient-centered outcomes research (01-06-2020)“…Objective This prospective, multicenter, non-interventional cohort study enrolling human immunodeficiency virus (HIV)-1-infected, virally suppressed adult…”
Get full text
Journal Article -
7
T-cell phenotype and function following a first cART regimen containing either a protease inhibitor or a non-nucleoside reverse transcriptase inhibitor in HIV-infected late presenters: results from a retrospective, ex vivo study
Published in Antiviral therapy (01-01-2016)“…We aimed to comparatively assess darunavir/ritonavir (DRV/r) and efavirenz (EFV)-based first-line cART regimens in the reconstitution of T-cell phenotype and…”
Get more information
Journal Article -
8
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression
Published in The patient : patient-centered outcomes research (01-08-2020)“…In the original version of this article, in Fig. 2b the formatting on the x-axis of the graph has been published incorrectly…”
Get full text
Journal Article -
9
Safety of darunavir/ritonavir (DRV/r) in HIV‐1‐infected DRV/r‐experienced and ‐naïve patients: analysis of data in the real‐world setting in Italy
Published in Journal of the International AIDS Society (01-11-2014)“…Introduction This descriptive, non‐interventional study on HIV‐1‐infected patients treated with DRV/r in the usual clinical setting, with a single‐arm…”
Get full text
Journal Article -
10
Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r‐experienced HIV‐1‐infected patients in routine clinical practice
Published in Journal of the International AIDS Society (01-11-2014)“…Introduction This was a descriptive non‐interventional study in HIV‐1‐infected patients treated with DRV/r conducted in the clinical setting, with a single‐arm…”
Get full text
Journal Article -
11
Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study
Published in Drug design, development and therapy (01-01-2016)“…Current antiretroviral (ARV) therapy for the treatment of human immunodeficiency virus (HIV-1)-infected patients provides long-term control of viral load (VL)…”
Get full text
Journal Article